Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects

• Autores principales: Ralf Uebelhack (Autor), Udo Bongartz (Autor), Stephanie Seibt (Autor), Gordana Bothe (Autor), Pee Win Chong (Autor), Patricia De Costa (Autor), Natalia Wszelaki (Autor)
• Formato: Libro
• Publicado: Hindawi Limited, 2019-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Objective. This study was performed to determine the efficacy and tolerability/safety of IQP-AE-103 on body weight reduction in overweight to moderately obese adults. Methods. A double-blind, randomized, placebo-controlled trial involved one hundred and eight subjects (BMI between 25 and 35 kg/m2) t...